Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)
Public ClinicalTrials.gov record NCT01438775. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Multicenter Prospective Open Label Clinical Safety Evaluation of Re-Injection of NX-1207 for the Treatment of BPH: Two Doses 1-7 Years Apart
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to demonstrate the safety and efficacy of a second transrectal intraprostatic injection of NX-1207 given to subjects with Benign Prostatic Hyperplasia (BPH) who previously received an injection of NX-1207 in an earlier U.S. clinical trial of NX-1207.
Study identification
- NCT ID
- NCT01438775
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 192 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2011 (Type not available)
- Primary completion
- Jan 2013 (Actual)
- Completion
- Jan 2013 (Actual)
- Last update posted
- Apr 30, 2014
2011 – 2013
United States locations
- U.S. sites
- 28
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Huntsville | Alabama | 35801 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Atherton | California | 94027 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | San Diego | California | 92103 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Tarzana | California | 91356 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Denver | Colorado | 80211 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Englewood | Colorado | 80113 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | New Britain | Connecticut | 06052 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Sarasota | Florida | 34237 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Meridian | Idaho | 83642 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Forest Hill | Indiana | 47630 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Jeffersonville | Indiana | 47130 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Shreveport | Louisiana | 71106 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Annapolis | Maryland | 21401 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Southaven | Mississippi | 38671 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Missoula | Montana | 59808 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Lawrenceville | New Jersey | 08648 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Albuquerque | New Mexico | 87109 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Brooklyn | New York | 11215 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Garden City | New York | 11530 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | New York | New York | 10016 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Poughkeepsie | New York | 12601 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Concord | North Carolina | 28025 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | Bismarck | North Dakota | 58501 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Lancaster | Pennsylvania | 17604 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Memphis | Tennessee | 38119 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Arlington | Texas | 76017 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669. | Houston | Texas | 77024 | — |
| For information concerning this clinical site, please contact Nymox at 800-936-9669 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01438775, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2014 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01438775 live on ClinicalTrials.gov.